No evidence for induction of autoantibodies or autoimmunity during treatment of psoriasis with ustekinumab

Br J Dermatol. 2017 Sep;177(3):862-863. doi: 10.1111/bjd.15654. Epub 2017 Jul 19.

Authors

P Rodríguez-Jiménez¹, P Chicharro¹, A Godoy², M Llamas-Velasco¹, M García³, E Daudén¹

Affiliations

¹ Department of Dermatology, Instituto de Investigación Sanitaria Princesa (IIS-IP), Hospital Universitario la Princesa, Madrid, Spain.
² Department of Dermatology, Hospital Universitario Puerta del Sur de Móstoles, Madrid, Spain.
³ Department of Immunology, Instituto de Investigación Sanitaria Princesa (IIS-IP), Hospital Universitario la Princesa, Madrid, Spain.

PMID: 28508387
DOI: 10.1111/bjd.15654

No abstract available

Publication types

Letter
Observational Study

MeSH terms

Antibodies, Antinuclear / metabolism
Antigens, Nuclear / metabolism
Autoantibodies / metabolism*
Autoimmunity / drug effects*
Dermatologic Agents / therapeutic use*
Female
Humans
Longitudinal Studies
Male
Middle Aged
Prospective Studies
Psoriasis / drug therapy*
Psoriasis / immunology
Ustekinumab / therapeutic use*

Substances

Antibodies, Antinuclear
Antigens, Nuclear
Autoantibodies
Dermatologic Agents
Ustekinumab